HIGHLIGHTS
- who: Yasmin Hisham and collaborators from the France University of Saint Joseph, United States have published the research: COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2, in the Journal: (JOURNAL)
- what: By narrowing a pool of spike antigens, the authors aimed to maximize the effectiveness of vaccine candidates. The authors sought to evaluate the efficacy of two proposed SARS-CoV2 vaccines, vaccine A and vaccine B, in providing protection against infection with the virus.
- future: More detailed investigations are needed to evaluate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.